Vivani Medical
VANI
56 hedge funds and large institutions have $9.74M invested in Vivani Medical in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 9 closing their positions.
112% more call options, than puts
Call options by funds: $280K | Put options by funds: $132K
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
4% less capital invested
Capital invested by funds: $10.2M → $9.74M (-$444K)
2% less funds holding
Funds holding: 57 → 56 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$211K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$172K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$159K |
| 4 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
+$74.9K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$431K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$164K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$159K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$102K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$57K |
VANI Hedge Fund Activity: Q3 2016 in Review
56 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2016, worth a combined $9.74M — down 4.4% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VANI and 8 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 17 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $211K. The largest seller was Goldman Sachs, exiting entirely with an estimated $431K sold.
- 56 institutional investors held Vivani Medical (VANI) as of Q3 2016, down from 57 in Q2 2016.
- Funds reported $9.74M of Vivani Medical stock for Q3 2016, down 4.4% quarter-over-quarter.
- 8 funds opened new Vivani Medical positions in Q3 2016 and 9 closed out, a net change of -1 holder.
- The largest Vivani Medical buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $211K added.
- The largest Vivani Medical seller in Q3 2016 was Goldman Sachs, an estimated $431K sold.
Based on aggregated 13F filings for Q3 2016.